{
  "symbol": "MO",
  "year": 2024,
  "Period": "Q2",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1847,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.139
  },
  "top_positive": [
    {
      "sent": "The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 7,855 $ 1,923 $ 5,932 $ 3.41 NPM Adjustment Items (6) (1) (5) \u2014 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 68 16 52 0.03 ABI-related special items (62) (14) (48) (0.02) Cronos-related special items 20 1 19 0.01 Income tax items \u2014 52 (52) (0.03) 2024 Adjusted for Special Items $ 5,672 $ 1,392 $ 4,280 $ 2.46 2023 Reported $ 5,285 $ 1,381 $ 3,904 $ 2.18 Acquisition and disposition-related items 1 \u2014 1 \u2014 Tobacco and health and certain other litigation items 401 100 301 0.17 Loss on disposition of JUUL equity securities 250 \u2014 250 0.14 ABI-related special items (28) (6) (22) (0.01) Cronos-related special items 30 \u2014 30 0.02 2023 Adjusted for Special Items $ 5,939 $ 1,475 $ 4,464 $ 2.50 43 Table of Contents The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the three months ended June\u00a030: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 5,116 $ 1,313 $ 3,803 $ 2.21 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 44 11 33 0.02 ABI-related special items 24 5 19 0.01 Cronos-related special items 3 1 2 \u2014 Income tax items \u2014 (19) 19 0.01 2024 Adjusted for Special Items $ 2,984 $ 726 $ 2,258 $ 1.31 2023 Reported $ 2,806 $ 689 $ 2,117 $ 1.19 Acquisition and disposition-related items 18 5 13 \u2014 Tobacco and health and certain other litigation items 290 73 217 0.12 ABI-related special items (3) (1) (2) \u2014 Cronos-related special items 4 \u2014 4 \u2014 Income tax items \u2014 3 (3) \u2014 2023 Adjusted for Special Items $ 3,115 $ 769 $ 2,346 $ 1.31 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2024 and 2023: \u25aa Acquisition and disposition-related items: We recorded a pre-tax gain of $2.7 billion upon the assignment of the IQOS Tobacco Heating System (\u201c IQOS System\u201d) commercialization rights to Philip Morris International Inc.",
      "score": 0.992
    },
    {
      "sent": "The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 7,855 $ 1,923 $ 5,932 $ 3.41 NPM Adjustment Items (6) (1) (5) \u2014 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 68 16 52 0.03 ABI-related special items (62) (14) (48) (0.02) Cronos-related special items 20 1 19 0.01 Income tax items \u2014 52 (52) (0.03) 2024 Adjusted for Special Items $ 5,672 $ 1,392 $ 4,280 $ 2.46 2023 Reported $ 5,285 $ 1,381 $ 3,904 $ 2.18 Acquisition and disposition-related items 1 \u2014 1 \u2014 Tobacco and health and certain other litigation items 401 100 301 0.17 Loss on disposition of JUUL equity securities 250 \u2014 250 0.14 ABI-related special items (28) (6) (22) (0.01) Cronos-related special items 30 \u2014 30 0.02 2023 Adjusted for Special Items $ 5,939 $ 1,475 $ 4,464 $ 2.50 43 Table of Contents The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the three months ended June\u00a030: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 5,116 $ 1,313 $ 3,803 $ 2.21 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 44 11 33 0.02 ABI-related special items 24 5 19 0.01 Cronos-related special items 3 1 2 \u2014 Income tax items \u2014 (19) 19 0.01 2024 Adjusted for Special Items $ 2,984 $ 726 $ 2,258 $ 1.31 2023 Reported $ 2,806 $ 689 $ 2,117 $ 1.19 Acquisition and disposition-related items 18 5 13 \u2014 Tobacco and health and certain other litigation items 290 73 217 0.12 ABI-related special items (3) (1) (2) \u2014 Cronos-related special items 4 \u2014 4 \u2014 Income tax items \u2014 3 (3) \u2014 2023 Adjusted for Special Items $ 3,115 $ 769 $ 2,346 $ 1.31 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2024 and 2023: \u25aa Acquisition and disposition-related items: We recorded a pre-tax gain of $2.7 billion upon the assignment of the IQOS Tobacco Heating System (\u201c IQOS System\u201d) commercialization rights to Philip Morris International Inc.",
      "score": 0.992
    },
    {
      "sent": "The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 7,855 $ 1,923 $ 5,932 $ 3.41 NPM Adjustment Items (6) (1) (5) \u2014 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 68 16 52 0.03 ABI-related special items (62) (14) (48) (0.02) Cronos-related special items 20 1 19 0.01 Income tax items \u2014 52 (52) (0.03) 2024 Adjusted for Special Items $ 5,672 $ 1,392 $ 4,280 $ 2.46 2023 Reported $ 5,285 $ 1,381 $ 3,904 $ 2.18 Acquisition and disposition-related items 1 \u2014 1 \u2014 Tobacco and health and certain other litigation items 401 100 301 0.17 Loss on disposition of JUUL equity securities 250 \u2014 250 0.14 ABI-related special items (28) (6) (22) (0.01) Cronos-related special items 30 \u2014 30 0.02 2023 Adjusted for Special Items $ 5,939 $ 1,475 $ 4,464 $ 2.50 43 Table of Contents The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the three months ended June\u00a030: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 5,116 $ 1,313 $ 3,803 $ 2.21 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 44 11 33 0.02 ABI-related special items 24 5 19 0.01 Cronos-related special items 3 1 2 \u2014 Income tax items \u2014 (19) 19 0.01 2024 Adjusted for Special Items $ 2,984 $ 726 $ 2,258 $ 1.31 2023 Reported $ 2,806 $ 689 $ 2,117 $ 1.19 Acquisition and disposition-related items 18 5 13 \u2014 Tobacco and health and certain other litigation items 290 73 217 0.12 ABI-related special items (3) (1) (2) \u2014 Cronos-related special items 4 \u2014 4 \u2014 Income tax items \u2014 3 (3) \u2014 2023 Adjusted for Special Items $ 3,115 $ 769 $ 2,346 $ 1.31 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2024 and 2023: \u25aa Acquisition and disposition-related items: We recorded a pre-tax gain of $2.7 billion upon the assignment of the IQOS Tobacco Heating System (\u201c IQOS System\u201d) commercialization rights to Philip Morris International Inc.",
      "score": 0.992
    }
  ],
  "top_negative": [
    {
      "sent": "(4) Includes as of July 29, 2024, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "(4) Includes as of July 29, 2024, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "Plaintiffs\u2019 allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.",
      "score": -0.9382
    }
  ],
  "forward_snippets": [
    "This guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.",
    "This guidance also specifies required disclosures for equity securities subject to contractual sale restrictions.",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 15.",
    "New Accounting Guidance Not Yet Adopted .",
    "This guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value."
  ],
  "curated_text": "Symbol: MO. Year: 2024. Period: Q2. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 7,855 $ 1,923 $ 5,932 $ 3.41 NPM Adjustment Items (6) (1) (5) \u2014 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 68 16 52 0.03 ABI-related special items (62) (14) (48) (0.02) Cronos-related special items 20 1 19 0.01 Income tax items \u2014 52 (52) (0.03) 2024 Adjusted for Special Items $ 5,672 $ 1,392 $ 4,280 $ 2.46 2023 Reported $ 5,285 $ 1,381 $ 3,904 $ 2.18 Acquisition and disposition-related items 1 \u2014 1 \u2014 Tobacco and health and certain other litigation items 401 100 301 0.17 Loss on disposition of JUUL equity securities 250 \u2014 250 0.14 ABI-related special items (28) (6) (22) (0.01) Cronos-related special items 30 \u2014 30 0.02 2023 Adjusted for Special Items $ 5,939 $ 1,475 $ 4,464 $ 2.50 43 Table of Contents The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the three months ended June\u00a030: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 5,116 $ 1,313 $ 3,803 $ 2.21 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 44 11 33 0.02 ABI-related special items 24 5 19 0.01 Cronos-related special items 3 1 2 \u2014 Income tax items \u2014 (19) 19 0.01 2024 Adjusted for Special Items $ 2,984 $ 726 $ 2,258 $ 1.31 2023 Reported $ 2,806 $ 689 $ 2,117 $ 1.19 Acquisition and disposition-related items 18 5 13 \u2014 Tobacco and health and certain other litigation items 290 73 217 0.12 ABI-related special items (3) (1) (2) \u2014 Cronos-related special items 4 \u2014 4 \u2014 Income tax items \u2014 3 (3) \u2014 2023 Adjusted for Special Items $ 3,115 $ 769 $ 2,346 $ 1.31 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2024 and 2023: \u25aa Acquisition and disposition-related items: We recorded a pre-tax gain of $2.7 billion upon the assignment of the IQOS Tobacco Heating System (\u201c IQOS System\u201d) commercialization rights to Philip Morris International Inc. The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 7,855 $ 1,923 $ 5,932 $ 3.41 NPM Adjustment Items (6) (1) (5) \u2014 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 68 16 52 0.03 ABI-related special items (62) (14) (48) (0.02) Cronos-related special items 20 1 19 0.01 Income tax items \u2014 52 (52) (0.03) 2024 Adjusted for Special Items $ 5,672 $ 1,392 $ 4,280 $ 2.46 2023 Reported $ 5,285 $ 1,381 $ 3,904 $ 2.18 Acquisition and disposition-related items 1 \u2014 1 \u2014 Tobacco and health and certain other litigation items 401 100 301 0.17 Loss on disposition of JUUL equity securities 250 \u2014 250 0.14 ABI-related special items (28) (6) (22) (0.01) Cronos-related special items 30 \u2014 30 0.02 2023 Adjusted for Special Items $ 5,939 $ 1,475 $ 4,464 $ 2.50 43 Table of Contents The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the three months ended June\u00a030: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 5,116 $ 1,313 $ 3,803 $ 2.21 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 44 11 33 0.02 ABI-related special items 24 5 19 0.01 Cronos-related special items 3 1 2 \u2014 Income tax items \u2014 (19) 19 0.01 2024 Adjusted for Special Items $ 2,984 $ 726 $ 2,258 $ 1.31 2023 Reported $ 2,806 $ 689 $ 2,117 $ 1.19 Acquisition and disposition-related items 18 5 13 \u2014 Tobacco and health and certain other litigation items 290 73 217 0.12 ABI-related special items (3) (1) (2) \u2014 Cronos-related special items 4 \u2014 4 \u2014 Income tax items \u2014 3 (3) \u2014 2023 Adjusted for Special Items $ 3,115 $ 769 $ 2,346 $ 1.31 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2024 and 2023: \u25aa Acquisition and disposition-related items: We recorded a pre-tax gain of $2.7 billion upon the assignment of the IQOS Tobacco Heating System (\u201c IQOS System\u201d) commercialization rights to Philip Morris International Inc. The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the six months ended June 30: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 7,855 $ 1,923 $ 5,932 $ 3.41 NPM Adjustment Items (6) (1) (5) \u2014 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 68 16 52 0.03 ABI-related special items (62) (14) (48) (0.02) Cronos-related special items 20 1 19 0.01 Income tax items \u2014 52 (52) (0.03) 2024 Adjusted for Special Items $ 5,672 $ 1,392 $ 4,280 $ 2.46 2023 Reported $ 5,285 $ 1,381 $ 3,904 $ 2.18 Acquisition and disposition-related items 1 \u2014 1 \u2014 Tobacco and health and certain other litigation items 401 100 301 0.17 Loss on disposition of JUUL equity securities 250 \u2014 250 0.14 ABI-related special items (28) (6) (22) (0.01) Cronos-related special items 30 \u2014 30 0.02 2023 Adjusted for Special Items $ 5,939 $ 1,475 $ 4,464 $ 2.50 43 Table of Contents The following table provides a reconciliation of adjusted net earnings and adjusted diluted EPS for the three months ended June\u00a030: (in millions of dollars, except per share data) Earnings before Income Taxes Provision for Income Taxes Net Earnings Diluted EPS 2024 Reported $ 5,116 $ 1,313 $ 3,803 $ 2.21 Acquisition and disposition-related items (2,557) (675) (1,882) (1.09) Asset impairment 354 90 264 0.15 Tobacco and health and certain other litigation items 44 11 33 0.02 ABI-related special items 24 5 19 0.01 Cronos-related special items 3 1 2 \u2014 Income tax items \u2014 (19) 19 0.01 2024 Adjusted for Special Items $ 2,984 $ 726 $ 2,258 $ 1.31 2023 Reported $ 2,806 $ 689 $ 2,117 $ 1.19 Acquisition and disposition-related items 18 5 13 \u2014 Tobacco and health and certain other litigation items 290 73 217 0.12 ABI-related special items (3) (1) (2) \u2014 Cronos-related special items 4 \u2014 4 \u2014 Income tax items \u2014 3 (3) \u2014 2023 Adjusted for Special Items $ 3,115 $ 769 $ 2,346 $ 1.31 The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2024 and 2023: \u25aa Acquisition and disposition-related items: We recorded a pre-tax gain of $2.7 billion upon the assignment of the IQOS Tobacco Heating System (\u201c IQOS System\u201d) commercialization rights to Philip Morris International Inc. Top negative sentences: (4) Includes as of July 29, 2024, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. (4) Includes as of July 29, 2024, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. Plaintiffs\u2019 allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes. Forward-looking snippets: This guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This guidance also specifies required disclosures for equity securities subject to contractual sale restrictions. For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 15. New Accounting Guidance Not Yet Adopted . This guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value."
}